Helping patients make informed decisions

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Update on lichen planus and its clinical variants Gillian Weston, MSIII, Michael Payette, MD, MBA International Journal of Women's Dermatology Volume 1,
Volume 60, Issue 4, Pages (October 2011)
Volume 60, Issue 2, Pages (August 2011)
Volume 69, Issue 5, Pages (May 2016)
The PSA Era is not Over for Prostate Cancer
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate.
P. Therasse, S. Carbonnelle, J. Bogaerts 
David Lorente, Karim Fizazi, Christopher Sweeney, Johann S. de Bono 
Volume 60, Issue 2, Pages (August 2011)
Evaluation of Proteinuria
Volume 68, Issue 1, Pages (July 2015)
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma  M. Ashton, N. O'Rourke, N.
Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer  Delmy Oliva, Mats Nilsson, Bengt-Åke Andersson,
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Counselling the Prostate Cancer Patient
Volume 122, Issue 7, Pages (June 2002)
Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient  P. Helbling  Clinical Microbiology.
The PSA Era is not Over for Prostate Cancer
Volume 120, Issue 2, Pages (February 2001)
Pain in cancer survivors; filling in the gaps
Physics and Imaging in Radiation Oncology
Role of Checkpoint Inhibition in Localized Bladder Cancer
Laure B. Bindels, Jean-Paul Thissen  Clinical Nutrition Experimental 
In This Issue Cell Volume 158, Issue 5, (August 2014)
Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians)  Carsten Nieder, Thomas A.
Clinical and Translational Radiation Oncology
Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy  Antoine Schernberg, Pierre Blanchard, Cyrus.
Clinical and Translational Radiation Oncology
PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed.
Epidemiology of opportunistic infections in AIDS patients
Jojanneke M. Seinen, Maarten G
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
Changes in apparent diffusion coefficient radiomics features during dose-painted radiotherapy and high dose rate brachytherapy for prostate cancer  Sangjune.
Volume 122, Issue 7, Pages (June 2002)
Clinical and Translational Radiation Oncology
Roy Hertz, M.D. (1909–2002): The cure of choriocarcinoma and its impact on the development of chemotherapy for cancer  Jonathan P Yarris, B.S., Alan J.
Physics and Imaging in Radiation Oncology
Follow up results of a prospective study to evaluate the impact of FDG-PET on CT- based radiotherapy treatment planning for oesophageal cancer  Sweet Ping.
The origins of multidisciplinary cancer care
Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.
Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung.
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx:
Jean-Emmanuel Bibault, Ingeborg Tinhofer 
Volume 69, Issue 5, Pages (May 2016)
Cancer clinical trials – Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC)  Kerstin A. Kessel,
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
FORECAST – A cloud-based personalized intelligent virtual coaching platform for the well-being of cancer patients  Sofoklis Kyriazakos, Vincenzo Valentini,
What is the impact of diabetes mellitus on radiation induced acute proctitis after radical radiotherapy for adenocarcinoma prostate? A prospective longitudinal.
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor.
Jean-Emmanuel Bibault, Pierfrancesco Franco, Gerben R
Clinical and radiobiological evaluation of a method for planning target volume generation dependent on organ-at-risk exclusions in magnetic resonance.
Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer  Garrett L. Jensen, Pierre Blanchard, G. Brandon Gunn, Adam.
Chronic Diarrhea Clinical Gastroenterology and Hepatology
Uncertainty evaluation of image-based tumour control probability models in radiotherapy of prostate cancer using a visual analytic tool  Oscar Casares-Magaz,
Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas  Debra Nana Yeboa, James B. Yu,
Telehealth in radiation oncology at the Townsville Cancer Centre: Service evaluation and patient satisfaction  Elizabeth Hamilton, Ellie Van Veldhuizen,
Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients  Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen,
Technical Innovations and Patient Support in Radiation Oncology
Patterns of practice in palliative radiotherapy for bleeding tumours in the Netherlands; a survey study among radiation oncologists  Jennifer Strijbos,
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Impact of antibiotic restrictions: the patient's perspective
Guru Sonpavde, MD, Teresa G. Hayes, MD  Mayo Clinic Proceedings 
Technical Innovations and Patient Support in Radiation Oncology
Clinical and Translational Radiation Oncology
Robert Comis, MD, The Passing of a “Lung Man”
Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy  Mercy Ofuya, Lucy McParland, Louise Murray,
Presentation transcript:

Helping patients make informed decisions Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic  Anna Patrikidou, Pierre Maroun, Jean-Jacques Patard, Hervé Baumert, Laurence Albiges, Christophe Massard, Yohann Loriot, Bernard Escudier, Mario Di Palma, Julia Arfi-Rouche, Laurence Rocher, Zahira Merabet, Alberto Bossi, Karim Fizazi, Pierre Blanchard  Clinical and Translational Radiation Oncology  Volume 12, Pages 28-33 (August 2018) DOI: 10.1016/j.ctro.2018.07.001 Copyright © 2018 The Authors Terms and Conditions

Fig. 1 PCMC study consort diagram. Clinical and Translational Radiation Oncology 2018 12, 28-33DOI: (10.1016/j.ctro.2018.07.001) Copyright © 2018 The Authors Terms and Conditions